Single-Photon Emission Computed Tomography (SPECT) Market to Reach $3.3 Billion by 2028 with 7.9% CAGR, Driven by Rising Cancer Prevalence and Technological Advancements

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Single-Photon Emission Computed Tomography (SPECT) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $3.3 billion In 2028 At A CAGR Of 7.9%.

The single-photon emission computed tomography (spect) market size has grown strongly in recent years. It will grow from $2.27 billion in 2023 to $2.43 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growing diagnostic imaging needs, rising incidence of chronic diseases, advancements in radiopharmaceuticals, expanding aging population, increasing healthcare expenditure.

The single-photon emission computed tomography (spect) market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing emphasis on precision medicine, expanding applications in neurological imaging, global rise in cancer incidence, advancements in radiotracer development, integration into multimodal imaging systems. Major trends in the forecast period include enhanced image reconstruction techniques, mobile spect imaging services, growing emphasis on cardiac imaging, innovations in detector technology, increasing clinical research initiatives.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=9960&type=smp

Single-Photon Emission Computed Tomography (SPECT) Market Major Segments
The single-photon emission computed tomography (spect) market covered in this report is segmented -
1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems
2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Other End User

Key Driver - Rising Cancer Prevalence Driving The Single-Photon Emission Computed Tomography (SPECT) Market

The rise in the prevalence of cases of cancer is expected to propel the growth of the single-photon emission computed tomography (SPECT) market going forward. This rise in the number of cancer cases has resulted from a rise in the aging population, unhealthy lifestyle choices, and environmental factors. Single-photon emission computed tomography (SPECT) helps in the diagnosis, staging, and monitoring of cancer along with other imaging techniques like computed tomography (CT) and Magnetic Resonance Imaging (MRI) scans. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rise in the prevalence of cases of cancer is driving the growth of the single-photon emission computed tomography (SPECT) market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=9960&type=smp

Prominent Trend - Revolutionizing Imaging With Advancements Reshaping The Single-Photon Emission Computed Tomography (SPECT) Market

Technological advancements are a key trend gaining popularity in the single-photon emission computed tomography (SPECT) market. Companies operating in the single-photon emission computed tomography (SPECT) market are adopting new technologies like high-resolution imaging to sustain their position in the market. For instance, in June 2022, Siemens Healthcare, a Germany-based medical device and medical solution manufacturing company, launched the Symbia Pro. Spectra SPECT/CT Scanner. This Symbia Pro. Spectra SPECT/CT device has advanced imaging technology, improved accessibility, optimal low-dose imaging, automated SPECT motion correction, and customized clinical tools designed for imaging in cardiology, oncology, orthopedics, and neurology applications. This device also has the myExam Companion feature, which enables automated workflow guidance.

Single-Photon Emission Computed Tomography (SPECT) Market Players
Major companies operating in the single-photon emission computed tomography (spect) market report are GE Healthcare Technologies Inc., Siemens AG, Bruker Corporation, Digirad Corporation, Mediso Ltd., DDD-Diagnostic A/S, Bracco Diagnostic SpA, Cardinal Health Inc., Curium Pharma UK Ltd., Spectrum Dynamics Medical Inc., Koninklijke Philips N.V., Beijing Hamamatsu Photon Techniques Inc., Novartis AG, MIE Medical Imaging Electronics GmbH, Global Medical Solutions Private Limited, Canon Medical Systems Corporation, Esaote S.p.A., Invicro LLC, LambdaSpect Ltd., Mediso Medical Imaging Systems Ltd., MR Solutions Ltd., TriFoil Imaging Inc., Gamma Medica Inc., Guerbet SA, Lantheus Medical Imaging Inc., Neusoft Medical Systems Co. Ltd., NTP Radioisotopes SOC Ltd., SurgicEye GmbH, Cubresa Inc., NeuroLogica Corp. .

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the single-photon emission computed tomography (SPECT) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the single-photon emission computed tomography (SPECT) market report during the forecast period. The regions covered in the single-photon emission computed tomography (spect) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Single-Photon Emission Computed Tomography (SPECT) Market Report Structure
3. Single-Photon Emission Computed Tomography (SPECT) Market Trends And Strategies
4. Single-Photon Emission Computed Tomography (SPECT) Market - Macro Economic Scenario
5. Single-Photon Emission Computed Tomography (SPECT) Market Size And Growth
…..
27. Single-Photon Emission Computed Tomography (SPECT) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.